Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mudcat who wrote (23666)	7/29/1998 8:27:00 AM
From: Hippieslayer	Respond to of 32384

the reason, Mr Mudcat was probably the nice dilution that took place with the deal.

To: Mudcat who wrote (23666)	7/29/1998 10:45:00 AM
From: Machaon	Read Replies (1) \| Respond to of 32384

<< Why was hitting $17 a milestone. >> Exactly my point. You are very observant! <g> The question was: If biotechs and Ligand valuations are that simple, why is LGND $11 now, and why was it $17 last year, before they had two NDA's in front of the FDA? << Maybe if your sober today >> You mean: "Maybe, if you're sober today." Hmmmm!? The question is: Is an insult more, or less, meaningful if it comes from someone, who is somewhat illiterate? << ... you can explain why after Lgnd hit $17 that it lost about 40% of its value, in spite of all the good news that has come out? >> Again, you have badly missed the point of my original note. This doesn't surprise me. <g> The unfortunate fact is that I am being put into the position of discussing a complex biotech investment with someone of questionable intellect (similar to Fugazi), and who knows very little about Ligand. Mudrat, to correspond with you on this subject would be a waste of my time, especially when you lead off the question with an insult.